Rosen Law Firm reminds purchasers of Phreesia common stock during the class period from May 8, 2025 to March 30, 2026 that today, July 13, 2026, is the lead plaintiff deadline in a securities class action. If you purchased Phreesia common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The lawsuit alleges that defendants made false or misleading statements and concealed adverse facts about slowing demand and reduced visibility in key revenue streams, particularly weakened pharmaceutical marketing commitments in its Network Solutions segment. Investors with losses in excess of $100,000 are encouraged to secure counsel before the deadline.
Phreesia IncSecurities class action lawsuit alleges false statements about slowing demand and reduced visibility in key revenue streams.